ELDERLY DEPRESSIVES : USE OF MEDICINES WITH A POTENITAL TO CAUSE DEPRESSION by Sagar, R.S. et al.
Indian J. Psychiat. (1990), 32(1), 64-68 
ELDERLY DEPRESSIVES : USE OF MEDICINES WITH 
A POTENTIAL TO CAUSE DEPRESSION 
R. S. SAGAR
1, D. MOHAN
2, VINOD KUMAR
3, S. K. KHANDELWAL* 
SUMMARY 
The prevalence of use of medicines with a known potential to cause depression among 40 elderly depressives and 
20 matched controls was studied. Results showed that the prevalence was not significantly different between the 
two groups. Within the patient group, the prevalence was independent of the variables of sex, nature and severity 
of depression, and history of previous episodes of affective illness. While the results indicate that depressive illnesses 
secondary to the use of medicines are not common, the possibility of a medicine rarely inducing depression can not 
be ruled out. 
The physical morbidity of psychiatric 
patients increases with ago (Maguire and 
Granville-Grossman, 1968), and a high pre-
valence of physical illnesses has been demons-
trated among elderly depressives (Kay and 
Roih, 1955; Kinzie et al., 1968). The high 
prevalence of physical morbidity among the 
elderly invites multiple treatments, thereby 
increasing the possibility of averse drug 
reactions. A wide variety of pharmacologic 
agents used to treat physical illnesses in the 
elderly have been reported to give rise to 
symptoms of depression (Quslander, 1982). 
Whit lock and F.vans (1978) have listed app-
roximately 200 drugs that can cause depres-
sion as an adverse effect. But then; are no 
markers which can distinguish an iatrogenic 
derpession from one which is not. 
Indian studies have shown depression to 
be a common diagnosis among elderly psychia-
tric patients (Rainachandran and Sarada 
Mt'iiou, 1980; Venkoba Rao and Madhavan, 
1982). In view of the high physical morbi-
dity among the elderly and the consequent 
use of medicines, it could be expected that a 
certain proportion of depressive illnesses 
occuring among the elderlv are secondary to 
1. 
the use of medicines. If the proportion of 
such iatrogenic depressive illnesses is large 
enough to be clinically significant, one would 
expect to find the use of depressogenic medici-
nes to be significantly more frequent among the 
elderly depressives than among a comparable 
sample of general population. 
Most of the information in literature re-
garding the potential of specific medicines to 
cause depression emerged from case reports 
and studies on the prevalence of depression 
among people using such medicines (Quetsch 
et al., 1959; Wal, 1967; Nolan, 1982). 
There is a paucity of studies which examined 
the prevalence of use of depressogenic medi-
cines among people with a diagnosis of depres-
sive illness as compared to the prevalence 
among the general population. Such infor-
mation, by providing a rough estimate of 
the magnitude of the problem, would be 
valuable in increasing physicians awareness 
and in altering prescribing practices which 
might be harmful to the interests of the pati-
ent. Kinzie et al. (1986), reported 38% of 
elderly subjects with a depressive disorder to 
be using medicines which have a potential to 
cause depression. However, the significance 
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of Kinzie's findings is difficult to assess, as the 
study design did not include a suitable com-
parison group to control for the high base 
rate of physical illnesses requiring use of 
medicines by the elderly. 
The aims of the present study are (i) to 
study the prevalence of use of medicines with 
a potential to cause depression, among elderly 
out-patients with a diagnosed depressive ill-
ness, and (ii) to examine if such prevalence is 
significantly different from that among a 
group of matched controls. 
MATERIAL AND METHODS 
The study material was divided into two 
groups: "patient group" and "control 
group". The patient group comprised of 
40 consecutive patients aged 60years or above, 
attending the psychiatry OPD of the All 
India Institute of Medical Sciences, New 
Delhi, and diagnosed to have a depressive 
illness under one of the ICD-9 (WHO, 1978) 
categories. The control group comparised of 
20 subjects aged 60 years or above, group 
matched with the patient group for age and 
sex, and having no past or present history of 
psychiatric illness. They were drawn from 
visitors coming to see their friends or relatives 
admitted in the hospital. 
All members of both patient and control 
groups were subjected to the same methodo-
logy as described below: 
The identification and socio-demographic 
data were recorded for each subject, using a 
brief questionnaire. All the subjects were 
given the semi-structured psychiatric inter-
view. In the patient group this served to 
confirm the diagnosis of depression and its 
sub-type as per ICD-9 categories. In the 
control group it served to exclude the presence 
of any psychiatric illness either at present 
or in the past. The severity of depressive 
symptoms was measured, using the 17-item 
Hamilton Depression Rating Scale (Hamilton, 
1960). 
All the subjects were questioned in detail 
regarding the use of any medicines excluding 
those being used to treat the current depres-
sive illness in the patient group. The infor-
mation was further corroborated by scrutiny 
of prescription slips, where available. Details 
regarding the nature of medicines used and 
duration of use were recorded separately for 
each subject. Medicines that were not used 
for a minimum duration of 3 weeks in a month 
were excluded. 
The list of medicines thus obtained was 
divided into two groups as (1) medicines that 
have a known potential to cause depression as 
an adverse effect, and (2) medicines which 
have not been reported to be causally asso-
ciated with depression. Placing any given 
medicine in one of the two groups was based 
on data available from the literature. Those 
medicines which have consistently reported in 
literature as being associated with depression 
were placed in the first group, while other 
medicines which have not been so reported 
were placed in the second group. 
The data thus obtained for the two groups 
was compared on different variables, using 
the following statistical methods, where appli-
cable : 
Chi—-square test with Yate's correction. 
Fisher's exact test. 
Unpaired 't' tests. 
RESULTS 
The age and sex distribution and other 
sociodemographic variables of the patient 
group and control group arc shown in "Table 
1'. The two groups did not differ signifi-
cantly on any of the variables except place 
of residence, with 87.5% of the patient group 
coming from an urban location as against 
50% in the control group (X* = 8.1: d.f. = I; 
p<.01) 
The ICD-9 diagnoses given to subjects 
in the patient group was MDP depressed 
type for 28 (70%), MDP circular currently 
depressed for 6 (15%), neurotic depression 
for 4 (10%), and depressive disorder not 66  R. 8. SAOAR ET AL. 
Sex 
Male 
Female 
Age 
Range 
Mean Age 
Place of residence 
Urban 
Rural 
Education 
Uneducated 
Literate 
Above school level 
Marital status 
Widowed/Seper-
ated 
Marriage continuing 
TABLE 1 
Patients 
N : 40(%) 
21(52.5) 
19(47.5) 
60-76 
63.3(SD:4.65) 
35(87.5) 
5(12.5) 
14(35.0) 
8(20.0) 
18(45.0) 
11(27.5) 
29(72.5) 
Controls 
N : 20(%) 
11(55.0) 
9(45.0) 
60-74 
63.4(SD:4.35) 
10(50.0)* 
10(50.0)* 
6(30.0) 
6(30.0) 
8(40.0) 
3(51.0) 
17(85.0) 
•Difference significant at p< 0.01; X
2=8.1; d.f. = l. 
elsewhere classified for 2(5%). In 20(50%) 
subjects of the patient group, a past history 
of having had episodes of affecitive illness 
could be obtained. The seventy of depress-
ion as measured by the Hamilton Depression 
Rating Scale (HDRS) score ranged from 
16 to 37 for the patient group (mean : 23.93; 
SD : 3.76). For the control group, the range 
of HDRS scores was from 0 to 6 with a mean 
of 2.2. 
A total of 13 (32.5%) subjects of the 
patient group gave history of using medicines 
other than those prescribed for the current 
depressive illness. Of these, 10(25%) were 
using medicines with a known depressogenic 
potential. Among the control group 6(30%) 
gave history of using any medicines, and of 
them 3(15%) wen" using medicines with a 
known potential to cause depression. The 
difference between the two groups for the 
number ot subjects with a history of using 
medicines, or for those using medicines with 
a known potential to cause depression, was 
not statistically significant. 
The nature of medicines used by subjects 
in both groups arc shown in 'Table 2'. The 
two groups did not differ significantly for the 
number of subjects using any single group of 
medicines or for the number of subjects 
using more than one group of medicines 
(Table 2). 
TABUS 2. Nature of medicines used by patient and controls. 
Nature of medication 
Anti-hypertensives 
Others acting on cardio-
vascular system 
Psychoactive medicines 
Anti-inflammatory/ 
Analgesics 
For endocrinal dysfunction 
Other 
No. of subjects using 
more than one group of 
medicines 
Patients 
N : 40 (%) 
9 (22.5) 
3 (7.5) 
1(2.5) 
2 (5.0) 
2 (5.0) 
6 (15.0) 
7 (17.5) 
Controls 
N:20(%) 
Nil 
Nil 
2 (10.0) 
1 (5.0) 
3 (15.0) 
1 (5.0) 
1 (5.0) 
Difference between patient and control groups not 
significant at p < 0.05 level for any of the variables. 
The subjects within the patient group were 
sub-divided based on the variables of sex, 
nature of depression, severity of depression, 
and past history of having had episodes of 
affective illness. The sub-groups on each 
variable did not differ significantly from each 
other for the number of subjects nsing any 
medicines other than those prescribed for 
depression, or for those using medicines with 
known depressogenic potential (Table 3). 
DISCUSSION 
The study had been restricted to the geria-
tric age group because the adverse effects of 
medicines are more likely to be apparant in 
that age group. The elderly metabolise drugs 
more slowly, leading to longer plasma half-
life. Their lean body mass and impaired 
functional reserves of brain, kidneys and liver 
also reduce drug tolerance. In addition, the ELDERLY DEPRESSIVES : MEDICINES CAUSING DEPRESSION  67 
TABLE 3. Comparison of subjects within the patient group on 
different variables 
Variable 
Sex 
Male (N=21) 
Female (N= 19) 
Nature of depression 
MDP type (N=34) 
Non-MDP (N=6) 
Severity of depression 
HDRS score above 
No . of subjects 
using medici-
nes  other than 
those prescribed 
foi 
group mean (N=21) 
HDRS score below 
group mean (N = 19) 
Past episodes of affective 
illness 
Present (N = 20) 
Absent (N = 20) 
r depression 
(%) 
7 (33.3) 
6 (31.6) 
13 (38.2) 
Nil 
8 (38.1) 
5 (26.3) 
7 (35.0) 
6 (30.0) 
No. of subjects 
using medici-
nes with de-
pressogenic po-
tential (%) 
6 (28.6) 
4(21.1) 
10 (29.4) 
Nil 
6 (28.6) 
4(21.1) 
6 (30.0) 
4 (20.0) 
Difference between sub-groups not significant at 
p<0.05 level on any of the variables. 
higher physical morbidity among the gero-
psychiatric population (Maguire & Granville-
Grossman, 1968) causes them to be exposed 
to the use of medicines more often than would 
be the case with a younger age group. 
The results of the study have shown that 
the use of medicines for physical ailments was 
not significantly different between elderly de-
pressives and matched controls without a 
depressive illness, 25% of the depressives 
were using medicines with a known potential 
to give rise to depression. While this was 
lower than the figure of 38% reported by 
Kinzie et al. (1986), it did not differ signifi-
cantly from the figure of 15% found in the 
sample of matched controls. Since the pro-
portion of depressives and non-depressives 
using medicines with a depressogenic potential 
were not significantly different, the data would 
suggest that among the elderly, depressive 
illnesses caused by pharmacologic agents do 
not have a prevalence large enough to be clini-
cally alarming. 
Such a conclusion would be limited by 
the assumption that the potential of medicines 
to cause depression is the same on all indivi-
duals exposed to such medicines. The con-
clusion may not hold good if the medicines 
tend to act selectively and precipitate depres-
sion more often among individuals who are 
already predisposed to develop a depressive 
illness. To a limited extent, the latter hypo-
thesis can be tested by comparing the use of 
medicines with a depressogenic potential bet-
ween depressives with a past history of affec-
tive episode and those without such a his-
tory. In this study, 20(50%) of the elderly 
derpessives had past history of episodes of 
affective illness. Among them 6(30%) gave 
a history of using medicines with a depres-
sogenic potential, which was not significantly 
different from the figure of 4(20%) for those 
without a past history of affective illness 
(Table 3). In clinical practice, a persons' 
predisposition to develop a depressive illness 
is best indicated by a previous history of affec-
tive illness episodes. However, for a com-
prehensive evaluation of such predisposition, 
other factors such as family history, life events, 
personality and biological markers will also 
have to be considered. Addressing all these 
variables requires studies with a different 
methodology. 
Among specific groups of medicines, anti-
hypertensives have most often been repor-
ted to give rise to depression (Quetsch et al., 
1959; Waal, 1967; Pctrie et al., 1982). But 
the clinical relevance of these reports is clou-
ded by the fact that while some of the reports 
have associated the use of anti-hvpertensives 
to the occurrence of depressive symptoms 
(Waal, 1967), other have reported on the 
occurrence of depressive reactions (Quetsch 
et al., 1959) and depressive disorders (Petrie 
et al., 1982). In addition most of the studies 
are based on population exposed to anti-
hypertensives and have not been adequately 68  R. S. SAGAR ET AL. 
controlled for the high base rate of depressions 
amoti" the general population by using a 
suitable comparison group. In the present 
study, no single group of medicines was being 
used significantly more commonly by the 
patient group as compared to the control 
group (Table 2). Whether a drug rarely 
induces an otherwise common illness is diffi-
cult 10 determine (Zelnik, 1987). Thus, the 
results of this studv indicate that use of 
medicines is at best an infrequent cause of 
depressive illness among I he elderly, since the 
possibility of a medicine rarely giving rise 
to a depressive illness can not be ruled out. 
CONCLUSIONS 
Since depressive illnesses secondary to 
the use of medicines have been found to be 
uncommon, there is no reason for extreme 
clinical parsimony in prescribing medicines 
reported to be associated with depression. A 
necessary medicine need not be withheld in 
order to prevent the possibility of iatrogenic 
depression since such a possibility is very 
small. As the role of medicines in inducing 
depressive illnesses in people already predis-
posed to depression is not clearly established, 
it would be prudent to prescribe alternative 
medicines to people at high risk for develop-
ing the illness. To establish whether depressive 
illness can be an uncommon adverse effect 
of a medicine, studies with a different metho-
dology and on larger samples of population 
are required. In view of the elderly consti-
tuting a steadily growing segment of the total 
population as well as the high prevelance 
of physical and psychiatric morbidity among 
the aged, there is a necessity for studies which 
concentrate on the sub-group of geropsychia-
tric population. 
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